6505-14-578-5378
Amoxicillin Anhydrous
6505145785378 145785378 3400933054960
INC: 68901

Managed by  France
NSN Created on 10 Dec 2013
Data Last Changed 
January 2023
January 2023
NATO Update Count 
1
1
NATO Data Quality 
       

 Marketplace  6505-14-578-5378
 Marketplace  6505-14-578-5378
Need Help? 
Request a Quotation from participating marketplace vendors
Request a Quotation from participating marketplace vendors
 Related Documents  6505-14-578-5378  2+ Documents (More...)
 Related Documents  6505-14-578-5378  2+ Documents (More...) 
RQST NE Updated Every Day 6505-14-578-5378 RQST Updated Every Day 6505-14-578-5378 RQST NE Related Documents 
6505-14-578-5378 2+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/fr 6505-14-578-5378
/fsg-65/fsc-6505/fr 6505-14-578-5378 Every Day 6505-14-578-5378 RQST NE Related Documents 6505-14-578
6505-14-578-5378 2+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/fr 6505-14-578-5378
/fsg-65/fsc-6505/fr 6505-14-578-5378 Every Day 6505-14-578-5378 RQST NE Related Documents 6505-14-578
-574-0988 RQST NE Related Documents 6505-14-574 https//www.nsnlookup.com /fsg-65/fsc-6505/fr 6505-14-578-5378 
Amoxicillin Anhydrous 6505145785378 145785378 -578-5378 RQST NE Related Documents 6505-14-578 https
Panpharma (Active) Primary Buy RNCC 3 RNVC 2 DAC 4 NATO Stock Numbers Related to 6505-14-574-0988 6505-14-578-5378
Amoxicillin Anhydrous 6505145785378 145785378 -578-5378 RQST NE Related Documents 6505-14-578 https
Panpharma (Active) Primary Buy RNCC 3 RNVC 2 DAC 4 NATO Stock Numbers Related to 6505-14-574-0988 6505-14-578-5378
 Restrictions  6505-14-578-5378
 Restrictions  6505-14-578-5378
 End Users  6505-14-578-5378
 End Users  6505-14-578-5378
- France (ZF)
 Approved Sources  6505-14-578-5378
 Approved Sources  6505-14-578-5378
- Part Number- Manufacturer
- Status
- 3400933054960
- Manufacturer
-  F3236 - Laboratoire Glaxosmithkline (Active) - Primary Buy
- Primary Buy
 Similar Supply Items to 6505-14-578-5378
 Similar Supply Items to 6505-14-578-5378


















 
 